Parse Biosciences Extends RNA-Seq Kit Reach to Australia and New Zealand through Decode Sciences Agreement

Seattle, WA, October 11, 2021 Parse Biosciences, today announced a partnership with Decode Science to provide Parse’s single-cell RNA-seq solution to the Australian and New Zealand markets. Under an agreement between the parties, Decode Science has been appointed a distributor of the Parse product portfolio for Australia and New Zealand. Decode Science will provide customer service, technical […]

Read More

Parse Biosciences Launches Whole Transcriptome Kit to Dramatically Scale Single Cell Sequencing

Now commercially available, the Whole Transcriptome Kit enables researchers in neuroscience, immunology, oncology, as well as other areas of scientific study, to achieve industry-leading detail on cell types and subtypes Seattle, WA, February 18, 2021 Parse Biosciences., a company providing researchers with scalable and flexible single cell sequencing solutions, today announced the launch of their […]

Read More

Split Biosciences, now Parse Biosciences, Announces $7M in Series A Funding to Democratize Single-Cell RNA Sequencing

As adoption of scRNA-seq in industry and academia accelerates, Parse Biosciences (formerly Split Bio) offers the most flexible and scalable single cell sequencing kit, no custom instrument needed Seattle, WA, January 26, 2021 Split Biosciences, a company providing researchers scalable and flexible single cell sequencing solutions, today announced $7M in Series A funding. The funding […]

Read More